Products for Research Use Only
RegisterLogin

Bilastine

CAT: 0013-GTR19159901-01Size: 1 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19159901-01Size:1 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives) . It exerts its effect as a selective histamine H1 receptor antagonist, and has a potency similar to cetirizine and is superior to fexofenadine. It was developed in Spain by FAES Farma. Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.
CAS Number
202189-78-4
Product Name Alternative
Bilastine trade name Bilaxten
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 49.3 mg/mL; 106.34 mM
Smiles
CCOCCn1c (nc2ccccc12) C1CCN (CCc2ccc (cc2) C (C) (C) C (O) =O) CC1
Molecular Formula
C28H37N3O3
Molecular Weight
463.62
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2- (4- (2- (4- (1- (2-ethoxyethyl) -1H-benzo[d]imidazol-2-yl) piperidin-1-yl) ethyl) phenyl) -2-methylpropanoic acid

Alternative Products

CatalogName
C17274-25mgBilastine
CS-O-15080Bilastine-d6
A12661-100Bilastine 100mg
A12661-25Bilastine 25mg

Popular Products